Olfactory Carcinoma, Similar yet Distinct to Olfactory Neuroblastoma: A Case Report and Literature Review.

IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY
Mohammad Bilal Alsavaf, Basit Jawad, Eman H Salem, Kittichai Mongkolkul, Abberly Lott Limbach, Daniel M Prevedello, Ricardo Carrau
{"title":"Olfactory Carcinoma, Similar yet Distinct to Olfactory Neuroblastoma: A Case Report and Literature Review.","authors":"Mohammad Bilal Alsavaf, Basit Jawad, Eman H Salem, Kittichai Mongkolkul, Abberly Lott Limbach, Daniel M Prevedello, Ricardo Carrau","doi":"10.1159/000541170","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Olfactory carcinoma (OC) is a rare tumor that is often misdiagnosed as olfactory neuroblastoma (ONB). Due to its rarity, there is no established standard treatment for OC, and there have been no reports of successful long-term follow-up treatment yet.</p><p><strong>Case presentation: </strong>Two male patients, aged 54 and 48 years, presented with similar symptoms of nasal obstruction, anosmia, facial swelling, and epistaxis. Imaging in both cases revealed large, locally advanced sinonasal neoplasms. Initial biopsies were concerning for ONB; however, final pathological analyses confirmed high-grade OC. Treatment comprised induction chemotherapy, extensive skull base tumor resection, adjuvant chemoradiotherapy, and reconstructive surgery in both cases. The 54-year-old remains disease-free at 7 years, while the 48-year-old demonstrates no evidence of disease at 8 months.</p><p><strong>Conclusion: </strong>Accurate diagnostic differentiation is imperative to optimize a treatment approach. Although outcomes with OC tend to be worse than those of ONB, effective control can be achieved with judicious concurrent use of neoadjuvant, surgery, and adjuvant treatments. Ongoing surveillance, biobanking, and genomic analysis are crucial to gain a better understanding of this complex disease.</p>","PeriodicalId":49717,"journal":{"name":"Orl-Journal for Oto-Rhino-Laryngology Head and Neck Surgery","volume":" ","pages":"211-216"},"PeriodicalIF":2.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orl-Journal for Oto-Rhino-Laryngology Head and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000541170","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Olfactory carcinoma (OC) is a rare tumor that is often misdiagnosed as olfactory neuroblastoma (ONB). Due to its rarity, there is no established standard treatment for OC, and there have been no reports of successful long-term follow-up treatment yet.

Case presentation: Two male patients, aged 54 and 48 years, presented with similar symptoms of nasal obstruction, anosmia, facial swelling, and epistaxis. Imaging in both cases revealed large, locally advanced sinonasal neoplasms. Initial biopsies were concerning for ONB; however, final pathological analyses confirmed high-grade OC. Treatment comprised induction chemotherapy, extensive skull base tumor resection, adjuvant chemoradiotherapy, and reconstructive surgery in both cases. The 54-year-old remains disease-free at 7 years, while the 48-year-old demonstrates no evidence of disease at 8 months.

Conclusion: Accurate diagnostic differentiation is imperative to optimize a treatment approach. Although outcomes with OC tend to be worse than those of ONB, effective control can be achieved with judicious concurrent use of neoadjuvant, surgery, and adjuvant treatments. Ongoing surveillance, biobanking, and genomic analysis are crucial to gain a better understanding of this complex disease.

嗅癌,与嗅神经母细胞瘤相似但又有区别:病例报告和文献综述。
简介:嗅癌(OC)是一种罕见肿瘤,常被误诊为嗅神经母细胞瘤(ONB):嗅癌(OC)是一种罕见肿瘤,常被误诊为嗅神经母细胞瘤(ONB)。由于其罕见性,目前尚无针对嗅癌的标准治疗方法,也没有成功的长期随访治疗报告:两名分别为 54 岁和 48 岁的男性患者出现了类似的鼻塞、嗅觉障碍、面部肿胀和鼻衄症状。两例患者的影像学检查均发现局部晚期鼻窦肿瘤。最初的活检结果显示为 ONB,但最终病理分析证实为高级别 OC。治疗包括诱导化疗、大范围颅底肿瘤切除、辅助化放疗以及两例患者的重建手术。54 岁的患者在 7 年后仍未出现疾病,而 48 岁的患者在 8 个月后未出现疾病迹象:结论:准确的诊断鉴别对于优化治疗方法至关重要。结论:准确的诊断鉴别对优化治疗方法至关重要。虽然OC的治疗效果往往比ONB差,但通过合理地同时使用新辅助治疗、手术治疗和辅助治疗,可以有效控制病情。持续监测、生物库和基因组分析对于更好地了解这种复杂的疾病至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
7.70%
发文量
31
审稿时长
6-12 weeks
期刊介绍: ''ORL'' contains concise, original scientific papers of interest for both clinicians and researchers in oto-rhino-laryngology and head and neck surgery. Contributions drawn from the basic sciences cover new knowledge on the anatomy, pathology, pathophysiology, immunology and tumor biology of head and neck and the auditory and vestibular system, the salivary glands, paranasal sinuses and of the organs of the upper respiratory and digestive tract. The practical value of the journal is accentuated by reports of clinical progress in diagnosis and therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书